Geoffrey Mackay - 08 Feb 2023 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Reporting relationship: President & CEO, Director
Issuer ticker: TECX
Reported as of: 08 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Feb 2023, 16:08:28 UTC
Prior SEC filing: 26 Jan 2023
Next SEC filing: 14 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Steven Avruch, Attorney-in-Fact for Geoffrey MacKay

Key filing fact

Geoffrey Mackay filed Form 4 for AVROBIO, Inc. (TECX) on 10 Feb 2023.

Key facts

This page summarizes Geoffrey Mackay's Form 4 filing for AVROBIO, Inc. (TECX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Feb 2023, 16:08.

Change

Previous filing in this sequence was filed on 26 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVRO transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +300,667
Change %
Price: $0.000000
Shares after: 300,667
Date: 08 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 300,667
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.